Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The overall objective of this trial is to identify a safe and effective combination,
(coadministration) short course treatment for the treatment of visceral leishmaniasis which
could be easily deployed in a control programme and will reduce the risk of parasite
resistance occurring.
Safety and tolerability should be such that the combination can be easily deployed.
Phase:
Phase 3
Details
Lead Sponsor:
Drugs for Neglected Diseases
Treatments:
Amphotericin B Amphotericin B, deoxycholate drug combination Deoxycholic Acid Liposomal amphotericin B Miltefosine Paromomycin